CLDX vs FIS · rev $37.0K vs P/E 7.9, rev $6.67B
Celldex Therapeutics Inc (CLDX) versus Fidelity National Information Services Inc (FIS) — a side-by-side from cached financials, not a winner call.
Celldex Therapeutics Inc (CLDX) is a biotechnology company listed on US.
Fidelity National Information Services Inc (FIS) is a information technology services company listed on US.
Latest reported CLDX revenue for 2026-06-30 was $37.0K. Net income was -$152.2M. CLDX currently screens at market cap $2.35B.
Latest reported FIS revenue for 2026-06-30 was $6.67B. Net income was $2.60B. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
CLDX currently screens at market cap $2.35B. FIS currently screens at market cap $21.12B and trailing P/E 7.9.
Not investment advice. Open the CLDX and FIS stock pages for the full models.
Not investment advice.